Phillip A Sharp's Net Worth
$168 Million
Who is Phillip A Sharp?
Phillip A Sharp has an estimated net worth of $168 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC, ALNYLAM PHARMACEUTICALS, INC., Vir Biotechnology, Inc., and Syros Pharmaceuticals, Inc..
SEC CIK
Phillip A Sharp's CIK is 0001226295
Past Insider Trading and Trends
2004 was Phillip A Sharp's most active year for acquiring shares with 7 total transactions. Phillip A Sharp's most active month to acquire stocks was the month of May. 2008 was Phillip A Sharp's most active year for disposing of shares, totalling 75 transactions. Phillip A Sharp's most active month to dispose stocks was the month of March. 2008 saw Phillip A Sharp paying a total of $6,109,950.00 for 210,250 shares, this is the most they've acquired in one year. In 2014 Phillip A Sharp cashed out on 220,000 shares for a total of $9,350,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $200.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +0.48% | 2.25K |
—
|
—
| 470.28K |
Jun 3
| |||
Form 4
|
—
|
0
|
$51.71 | -$2,362,050.00 | 468.03K |
Scheduled
|
Jul 21
| ||
Form 4
| +0.44% | 2.05K |
—
|
—
| 468.03K |
Jul 9
| |||
Form 4
| -1.58% | -7.50K |
$64.86 | -$486,469.97 | 465.98K |
Scheduled
|
Apr 8
| ||
Form 4
| -3.20% | -15.65K |
$64.61 | -$1,011,197.65 | 473.48K |
Scheduled
|
Apr 8
| ||
Form 4
| +4.97% | 23.15K |
$50.09 | -$1,434,151.40 | 489.13K |
Scheduled
|
Apr 8
| ||
Form 4
| +0.50% | 2.3K |
—
|
—
| 465.98K |
May 31
| |||
Form 4
| +0.27% | 1.25K |
—
|
—
| 463.68K |
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 9
| |||
Form 4/A
| -0.59% | -5.90K |
$35.35 | -$3,798,220.00 | 992.9K |
May 4 - May 5
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| -3.30% | -14.40K |
—
|
—
| 421.63K |
Dec 2 - Dec 3
| |||
Form 4
| -8.78% | -41.97K |
—
|
—
| 436.03K |
Jul 16 - Aug 27
| |||
Form 4
| -38.09% | -294.10K |
$58.76 | -$17,281,807.95 | 478K |
May 14
| |||
Form 4
|
—
|
0
|
$34.87 | -$3,007,550.00 |
0
|
Apr 13 - May 13
| |||
Form 4/A
|
—
|
0
|
$35.37 | -$1,087,210.00 | 65K |
May 4
| |||
Form 4
| -5.93% | -55.90K |
$35.37 | -$4,384,720.00 | 887.1K |
Apr 5 - May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
∞
| 828K |
—
|
—
| 828K |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $246.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
$105.30 | -$2,762,570.94 |
0
|
Scheduled
|
Feb 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
$132.13 | -$6,623,670.08 |
0
|
Scheduled
|
Aug 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
|
—
|
0
|
$80.67 | -$4,160,100.00 |
0
|
Scheduled
|
Feb 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
| 266.9K |
Dec 7
| |||
Form 4
|
—
|
0
|
$67.10 | -$3,467,749.17 | 235.63K |
Scheduled
|
Nov 25
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
$71.24 | -$3,525,600.00 | 235.63K |
Scheduled
|
Feb 12
| ||
Form 4
|
—
|
0
|
$54.07 | -$1,129,211.70 | 235.63K |
Scheduled
|
Nov 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
$55.16 | -$992,092.00 | 235.63K |
Scheduled
|
Apr 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
$85.18 | -$1,914,750.00 | 140.79K |
Scheduled
|
Mar 13
| ||
Form 4
|
—
|
0
|
$78.14 | -$1,525,800.00 | 140.79K |
Scheduled
|
Mar 9
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
$35.55 | -$212,874.76 | 140.79K |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$34.67 | -$98,400.00 | 140.79K |
Scheduled
|
Jan 25
| ||
Form 4
|
—
|
0
|
$26.87 | -$328,806.00 | 140.79K |
Scheduled
|
Jan 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
$61.64 | -$2,841,600.00 | 140.79K |
Scheduled
|
Dec 4
| ||
Form 4
|
—
|
0
|
—
|
—
| 266.9K |
Jun 1
| |||
Form 4
|
—
|
0
|
$46.36 | -$8,502,200.00 | 266.9K |
Scheduled
|
Jul 9 - Oct 13
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
|
—
|
0
|
—
|
—
| 266.9K |
Jul 2 - Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
| +53.40% | 4.97K |
$20.13 | $99,985.71 | 14.27K |
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
∞
| 9.3K |
$10.75 | $99,996.50 | 9.3K |
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
| 252.63K |
May 27 - Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 10
| |||
Form 4
|
—
|
0
|
—
|
—
| 252.63K |
Apr 14 - Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
| 252.63K |
Sep 23 - Dec 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 12 - Dec 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +13.53% | 31.58K |
—
|
—
| 264.91K |
Jun 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vir Biotechnology, Inc. (VIR) Snapshot price: $7.63
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.23% | 6.03K |
—
|
—
| 121.17K |
May 22
| |||
Form 4
| +5.89% | 6.41K |
—
|
—
| 115.15K |
May 23
| |||
Form 4
| +3.20% | 3.37K |
—
|
—
| 108.74K |
May 21
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
| +1,348.42% | 222.22K |
—
|
—
| 238.7K |
Oct 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syros Pharmaceuticals, Inc. (SYRS) Snapshot price: $1.6
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
∞
| 266.67K |
—
|
—
| 266.67K |
Jul 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||